search
NASDAQ:URGN
USD
10.67
- (5.4%)
UROGEN PHARMA LTD.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
USD 10.67
- (5.4%)
End of Day: 8 May 2025 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

UroGen Pharma Ltd is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative solutions that treat urothelial and specialty cancers. The company has an innovativ...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices